These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 11741943)

  • 1. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
    Mendrola JM; Berger MB; King MC; Lemmon MA
    J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimerization of the transmembrane domain of Integrin alphaIIb subunit in cell membranes.
    Li R; Gorelik R; Nanda V; Law PB; Lear JD; DeGrado WF; Bennett JS
    J Biol Chem; 2004 Jun; 279(25):26666-73. PubMed ID: 15067009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two motifs within a transmembrane domain, one for homodimerization and the other for heterodimerization.
    Gerber D; Sal-Man N; Shai Y
    J Biol Chem; 2004 May; 279(20):21177-82. PubMed ID: 14985340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial synthesis, purification, and solubilization of transmembrane segments of ErbB family members].
    Goncharuk MV; Shul'ga AA; Ermoliuk IaS; Tkach EN; Goncharuk SA; Pustovalova IuE; Mineev KS; Bocharov ÉV; Maslennikov IV; Arsen'ev AS; Kirpichnikov MP
    Mol Biol (Mosk); 2011; 45(5):892-902. PubMed ID: 22393787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two GxxxG-like motifs facilitate promiscuous interactions of the human ErbB transmembrane domains.
    Escher C; Cymer F; Schneider D
    J Mol Biol; 2009 May; 389(1):10-6. PubMed ID: 19361517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant.
    Beevers AJ; Damianoglou A; Oates J; Rodger A; Dixon AM
    Biochemistry; 2010 Apr; 49(13):2811-20. PubMed ID: 20180588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.
    Stanley AM; Fleming KG
    J Mol Biol; 2005 Apr; 347(4):759-72. PubMed ID: 15769468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.
    Franco-Gonzalez JF; Ramos J; Cruz VL; Martínez-Salazar J
    J Mol Model; 2013 Feb; 19(2):931-41. PubMed ID: 23090500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for new homotypic and heterotypic interactions between transmembrane helices of proteins involved in receptor tyrosine kinase and neuropilin signaling.
    Sawma P; Roth L; Blanchard C; Bagnard D; Crémel G; Bouveret E; Duneau JP; Sturgis JN; Hubert P
    J Mol Biol; 2014 Dec; 426(24):4099-4111. PubMed ID: 25315821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TOXCAT: a measure of transmembrane helix association in a biological membrane.
    Russ WP; Engelman DM
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):863-8. PubMed ID: 9927659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the transmembrane helix associations of kit ligand by molecular dynamics simulation and TOXCAT.
    Chai M; Liu B; Sun F; Wei P; Chen P; Xu L; Luo SZ
    Proteins; 2017 Jul; 85(7):1362-1370. PubMed ID: 28370370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disabling receptor ensembles with rationally designed interface peptidomimetics.
    Berezov A; Chen J; Liu Q; Zhang HT; Greene MI; Murali R
    J Biol Chem; 2002 Aug; 277(31):28330-9. PubMed ID: 12011054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
    Muthuswamy SK; Gilman M; Brugge JS
    Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
    Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
    J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane peptides as inhibitors of ErbB receptor signaling.
    Bennasroune A; Fickova M; Gardin A; Dirrig-Grosch S; Aunis D; Crémel G; Hubert P
    Mol Biol Cell; 2004 Jul; 15(7):3464-74. PubMed ID: 15146055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by transmembrane peptides of chimeric insulin receptors.
    Bennasroune A; Gardin A; Auzan C; Clauser E; Dirrig-Grosch S; Meira M; Appert-Collin A; Aunis D; Crémel G; Hubert P
    Cell Mol Life Sci; 2005 Sep; 62(18):2124-31. PubMed ID: 16132228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.
    Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C
    J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.